Merrimack Pharma Stock Price (NASDAQ:MACK)

Add to My Stocks
$1.29 $0.01 (0.77%) MACK stock closing price Jul 21, 2017 (Closing)
Prev Close* : $1.30
Market Cap:
Day Low: $1.27
52 Week Low: $1.13
Open: $1.34
Volume: 623445
Day High: $1.34
52 Week High: $6.79

Latest Stock Market News

Latest Articles

Merrimack Pharma News - From Partners

MACK Stockcharts

View MACK PE ratio, PS ratio stocks charts and compare with peers.
MACK Chart
Note: Compare Merrimack Pharma stock price history with the index and industry peers.

Merrimack Pharma Valuation

PS ratio (
price to sales ratio

Merrimack Pharma Financial Ratios

Receivables Turnover

MACK Industry Peers

Company Price Change (%)
Viralytics (VRACY)2.290 (0%)
Medicinova (MNOV)5.430.12 (2.26%)
Baxter International (BAX)62.670.37 (0.59%)
Aduro Biotech (ADRO)13.750.05 (0.36%)
Newlink Genetics (NLNK)7.260.08 (1.09%)
Immune Pharma (IMNP)2.460.01 (0.4%)
Fibrogen (FGEN)34.950.3 (0.85%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Sarepta Therapeutics (SRPT)43.412.48 (6.06%)
Mirati Therapeutics (MRTX)4.90.25 (5.38%)
Cytokinetics (CYTK)14.50.65 (4.69%)
Fortress Biotech (FBIO)4.870.2 (4.28%)
Revance (RVNC)23.750.95 (4.17%)
BioDelivery Sciences (BDSI)3.250.1 (3.17%)
Compugen (CGEN)3.550.1 (2.9%)
Top gainers from Medical-Biomed-Genetics industry
* As of Jul 22, 2017
CompanyPriceChange (%)
Peregrine Pharma (PPHM)4.60.62 (11.88%)
Alimera Sciences (ALIM)1.450.13 (8.23%)
Trevena (TRVN)2.7550.22 (7.41%)
Vital Therapies (VTL)2.650.15 (5.36%)
ALBIREO PHARMA (ALBO)26.211.41 (5.1%)
Achillion Pharma (ACHN)4.110.21 (4.86%)
MannKind (MNKD)1.30.06 (4.41%)
Top losers from Medical-Biomed-Genetics industry
* As of Jul 22, 2017

Merrimack Pharmaceuticals Inc Stock News - Partner Headlines

Merrimack Pharma Financial Statements

income statement20162015201420132012
Net Sales Or Revenues144.27M89.25M102.75M47.78M48.92M
Net Income-151.74M-147.95M-83.29M-130.92M-91.27M
Total Operating Expense247.49M218.77M169M168.31M141.65M
view Merrimack Pharmaceuticals Inc income statement
balance sheet20162015201420132012
Total Assets81.48M234.88M158.65M192.41M148.97M
Total Liabilities332.6M418.8M260.79M235.88M155.39M
Shareholders Equity-251.12M-183.92M-102.14M-43.46M-6.42M
view Merrimack Pharmaceuticals Inc balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) In Assets Liabilities-62.06M14.57M23.1M14.98M-5.99M
Net Cash From (Used By) Operating Activities-170.24M-105.35M-34.8M-95.17M-79.81M
Increase (Decrease) In Prop Plant And Equipment-3.15M-12.78M-6.03M-9.85M-3.18M
view Merrimack Pharmaceuticals Inc cashflow statement

Merrimack Pharma Stock Message Board

An investor needs to spend 1.29 to buy MACK stock, as the closing Merrimack Pharma stock price is 1.29. Stock price or share price can be used to find the total market value of a company. Merrimack Pharma market cap stands at 172.56M as of 21 Jul, 2017. Merrimack Pharma valuation can be guaged using various valuation metrics like the price to earnings ratio.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that Merrimack Pharma is worth a lot, it will most likely be reflected in an inflated Merrimack Pharma stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. 623445 MACK shares were traded yesterday, and Merrimack Pharma stock chart shows that the MACK stock quote hit a day high of 1.34 and day low of 1.27. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. Merrimack Pharma stock price history, gives the entire historical data for MACK stock.